Although it is an intriguing hypothesis that the mutations in cell death pathways (CASP8, DIDO1) observed in head/neck cancer could be a tumor adaptation to ongoing immune activity, additional experiments will be necessary to establish this. Here, CASP8 is linked to head and neck cancer.